$23.67
+0.01
(+0.04%)▲
Revenue is down for the last 2 quarters, 178.55M → 178.20M (in $), with an average decrease of 0.2% per quarter
Netprofit is up for the last 2 quarters, -25.24M → 6.15M (in $), with an average increase of 510.0% per quarter
In the last 1 year, 10x Genomics Inc has given 53.9% return, outperforming this stock by 14.6%
0.17%
Downside
Day's Volatility :0.42%
Upside
0.25%
35.66%
Downside
52 Weeks Volatility :35.71%
Upside
0.08%
Period | Nextgen Healthcare, Inc. | Sector (Health Care) | Index (Russel 2000) |
---|---|---|---|
3 Months | 48.31% | 0.0% | 0.0% |
6 Months | 34.41% | 3.0% | -0.5% |
1 Year | 39.34% | 7.2% | 0.4% |
3 Years | 89.74% | 27.5% | 19.1% |
Market Capitalization | 1.3B |
Book Value | $6.12 |
Dividend Share | 0.0 |
Dividend Yield | 0.0% |
Earnings Per Share (EPS) | 0.03 |
PE Ratio | 644.33 |
PEG Ratio | 2.56 |
Wall Street Target Price | 20.77 |
Profit Margin | 0.35% |
Operating Margin TTM | 6.93% |
Return On Assets TTM | 3.98% |
Return On Equity TTM | 0.56% |
Revenue TTM | 678.1M |
Revenue Per Share TTM | 10.16 |
Quarterly Revenue Growth YOY | 16.2% |
Gross Profit TTM | 332.8M |
EBITDA | 56.3M |
Diluted Eps TTM | 0.03 |
Quarterly Earnings Growth YOY | 4.3 |
EPS Estimate Current Year | 0.96 |
EPS Estimate Next Year | 1.1 |
EPS Estimate Current Quarter | 0.22 |
EPS Estimate Next Quarter | 0.26 |
What analysts predicted
Downside of 12.25%
FY18 | Y/Y Change | |
---|---|---|
Revenue | 531.0M | ↑ 4.2% |
Net Income | 2.4M | ↓ 86.73% |
Net Profit Margin | 0.46% | ↓ 3.12% |
FY19 | Y/Y Change | |
---|---|---|
Revenue | 529.2M | ↓ 0.35% |
Net Income | 24.5M | ↑ 912.15% |
Net Profit Margin | 4.63% | ↑ 4.17% |
FY20 | Y/Y Change | |
---|---|---|
Revenue | 540.2M | ↑ 2.09% |
Net Income | 7.5M | ↓ 69.39% |
Net Profit Margin | 1.39% | ↓ 3.24% |
FY21 | Y/Y Change | |
---|---|---|
Revenue | 556.8M | ↑ 3.07% |
Net Income | 9.5M | ↑ 26.9% |
Net Profit Margin | 1.71% | ↑ 0.32% |
FY22 | Y/Y Change | |
---|---|---|
Revenue | 596.4M | ↑ 7.1% |
Net Income | 1.6M | ↓ 83.0% |
Net Profit Margin | 0.27% | ↓ 1.44% |
FY23 | Y/Y Change | |
---|---|---|
Revenue | 653.2M | ↑ 9.53% |
Net Income | -2.7M | ↓ 264.03% |
Net Profit Margin | -0.41% | ↓ 0.68% |
Q1 FY22 | Q/Q Change | |
---|---|---|
Revenue | 151.3M | ↑ 1.03% |
Net Income | 348.0K | ↓ 93.3% |
Net Profit Margin | 0.23% | ↓ 3.24% |
Q2 FY22 | Q/Q Change | |
---|---|---|
Revenue | 153.3M | ↑ 1.35% |
Net Income | 1.1M | ↑ 229.89% |
Net Profit Margin | 0.75% | ↑ 0.52% |
Q3 FY22 | Q/Q Change | |
---|---|---|
Revenue | 159.4M | ↑ 4.01% |
Net Income | 13.6M | ↑ 1086.67% |
Net Profit Margin | 8.54% | ↑ 7.79% |
Q4 FY22 | Q/Q Change | |
---|---|---|
Revenue | 161.9M | ↑ 1.53% |
Net Income | 7.8M | ↓ 42.63% |
Net Profit Margin | 4.83% | ↓ 3.71% |
Q1 FY23 | Q/Q Change | |
---|---|---|
Revenue | 178.6M | ↑ 10.3% |
Net Income | -25.2M | ↓ 422.97% |
Net Profit Margin | -14.14% | ↓ 18.97% |
Q2 FY23 | Q/Q Change | |
---|---|---|
Revenue | 178.2M | ↓ 0.19% |
Net Income | 6.2M | ↓ 124.39% |
Net Profit Margin | 3.45% | ↑ 17.59% |
FY18 | Y/Y Change | |
---|---|---|
Total Assets | 515.8M | ↑ 8.99% |
Total Liabilities | 192.3M | ↑ 14.37% |
FY19 | Y/Y Change | |
---|---|---|
Total Assets | 532.9M | ↑ 3.32% |
Total Liabilities | 156.9M | ↓ 18.4% |
FY20 | Y/Y Change | |
---|---|---|
Total Assets | 720.1M | ↑ 35.13% |
Total Liabilities | 319.6M | ↑ 103.65% |
FY21 | Y/Y Change | |
---|---|---|
Total Assets | 644.5M | ↓ 10.5% |
Total Liabilities | 212.8M | ↓ 33.41% |
FY22 | Y/Y Change | |
---|---|---|
Total Assets | 627.7M | ↓ 2.61% |
Total Liabilities | 204.6M | ↓ 3.87% |
Q1 FY22 | Q/Q Change | |
---|---|---|
Total Assets | 627.7M | ↑ 3.69% |
Total Liabilities | 204.6M | ↑ 5.36% |
Q2 FY22 | Q/Q Change | |
---|---|---|
Total Assets | 608.0M | ↓ 3.14% |
Total Liabilities | 179.1M | ↓ 12.44% |
Q3 FY22 | Q/Q Change | |
---|---|---|
Total Assets | 627.1M | ↑ 3.15% |
Total Liabilities | 185.3M | ↑ 3.44% |
Q4 FY22 | Q/Q Change | |
---|---|---|
Total Assets | 871.0M | ↑ 38.89% |
Total Liabilities | 453.3M | ↑ 144.61% |
Q1 FY23 | Q/Q Change | |
---|---|---|
Total Assets | 896.1M | ↑ 2.88% |
Total Liabilities | 495.7M | ↑ 9.36% |
Q2 FY23 | Q/Q Change | |
---|---|---|
Total Assets | 868.5M | ↓ 3.08% |
Total Liabilities | 457.9M | ↓ 7.61% |
FY18 | Y/Y Change | |
---|---|---|
Operating Cash Flow | 76.6M | ↓ 30.75% |
Investing Cash Flow | -91.5M | ↑ 702.57% |
Financing Cash Flow | 6.1M | ↓ 106.9% |
FY19 | Y/Y Change | |
---|---|---|
Operating Cash Flow | 50.5M | ↓ 34.09% |
Investing Cash Flow | -25.5M | ↓ 72.12% |
Financing Cash Flow | -21.6M | ↓ 453.78% |
FY20 | Y/Y Change | |
---|---|---|
Operating Cash Flow | 85.6M | ↑ 69.59% |
Investing Cash Flow | -96.1M | ↑ 276.41% |
Financing Cash Flow | 116.3M | ↓ 637.08% |
FY21 | Y/Y Change | |
---|---|---|
Operating Cash Flow | 98.5M | ↑ 15.09% |
Investing Cash Flow | -28.5M | ↓ 70.29% |
Financing Cash Flow | -131.7M | ↓ 213.29% |
FY22 | Y/Y Change | |
---|---|---|
Operating Cash Flow | 53.5M | ↓ 45.65% |
Investing Cash Flow | -28.1M | ↓ 1.62% |
Financing Cash Flow | -37.3M | ↓ 71.69% |
Q1 FY22 | Q/Q Change | |
---|---|---|
Operating Cash Flow | 16.9M | ↑ 4.65% |
Investing Cash Flow | -8.2M | ↑ 26.74% |
Financing Cash Flow | 3.7M | ↓ 110.02% |
Q2 FY22 | Q/Q Change | |
---|---|---|
Operating Cash Flow | -4.6M | ↓ 127.47% |
Investing Cash Flow | -9.5M | ↑ 15.17% |
Financing Cash Flow | -4.1M | ↓ 211.07% |
Q3 FY22 | Q/Q Change | |
---|---|---|
Operating Cash Flow | 38.4M | ↓ 927.58% |
Investing Cash Flow | 864.0K | ↓ 109.14% |
Financing Cash Flow | -9.3M | ↑ 127.09% |
Q4 FY22 | Q/Q Change | |
---|---|---|
Operating Cash Flow | 2.2M | ↓ 94.33% |
Investing Cash Flow | -56.6M | ↓ 6647.8% |
Financing Cash Flow | 225.5M | ↓ 2518.84% |
Company Name | 1 Month | 6 Month | 1 Year | 3 Years | 5 Years |
---|---|---|---|---|---|
![]() Nextgen Healthcare, Inc. | 46.47% | 34.41% | 39.34% | 89.74% | 15.58% |
![]() R1 Rcm Inc | -4.25% | 14.29% | -18.74% | 2.89% | 66.49% |
![]() 10x Genomics Inc | 0.41% | -7.17% | 50.31% | -62.71% | -13.86% |
![]() Veeva Systems Inc. | 11.4% | 18.3% | 25.61% | -22.85% | 101.63% |
![]() Ge Healthcare Technologies Inc. | -4.13% | -13.59% | 9.31% | 9.31% | 9.31% |
Company Name | P/E Ratio | P/B Ratio | PEG Ratio | EPS | ROE | ROA | Div Yield | BVPS |
---|---|---|---|---|---|---|---|---|
![]() Nextgen Healthcare, Inc. | 644.33 | 644.33 | 2.56 | 0.96 | 0.01 | 0.04 | 0.0 | 6.12 |
![]() R1 Rcm Inc | 128.18 | NA | 0.77 | 0.06 | -0.02 | 0.02 | 0.0 | 6.55 |
![]() 10x Genomics Inc | NA | NA | NA | -1.69 | -0.22 | -0.11 | 0.0 | 6.76 |
![]() Veeva Systems Inc. | 64.66 | 64.66 | 1.27 | 4.18 | 0.15 | 0.05 | 0.0 | 25.85 |
![]() Ge Healthcare Technologies Inc. | 19.51 | 19.51 | NA | 3.8 | 0.15 | 0.06 | 0.0 | 15.62 |
Company Name | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin |
---|---|---|---|---|---|
![]() Nextgen Healthcare, Inc. | Buy | $1.3B | 15.58% | 644.33 | 0.35% |
![]() R1 Rcm Inc | Buy | $6.7B | 66.49% | 128.18 | -3.09% |
![]() 10x Genomics Inc | Buy | $6.3B | -13.86% | NA | -30.31% |
![]() Veeva Systems Inc. | Buy | $33.4B | 101.63% | 64.66 | 24.2% |
![]() Ge Healthcare Technologies Inc. | Buy | $31.5B | 9.31% | 19.51 | 9.62% |
BlackRock Inc
Vanguard Group Inc
Dimensional Fund Advisors, Inc.
State Street Corporation
William Blair Investment Management, LLC
Capital Research Global Investors
nextgen healthcare information systems, llc, a wholly owned subsidiary of quality systems, inc., provides integrated clinical, financial, and connectivity solutions for primary care physicians, specialist physicians, health systems, and dental provider organizations. the company drives collaborative care and patient engagement with a comprehensive suite of products and services that support emerging initiatives such as patient-centered medical home, accountable care organizations, and health information exchange.
Organization | Nextgen Healthcare, Inc. |
Employees | 2783 |
CEO | Mr. David William Sides |
Industry | Technology Services |
Wearable Devices Ltd
$23.67
+0.04%
Barrett Business Services Inc
$23.67
+0.04%
Simplify Interest Rate Hedge Etf
$23.67
+0.04%
Invesco S&p Smallcap 600® Pure Value Etf
$23.67
+0.04%
American Century Quality Diversified International Etf
$23.67
+0.04%
Short Dow30 Proshares
$23.67
+0.04%
Franklin Street Properties Corp
$23.67
+0.04%
Nuveen Credit Strat Incm
$23.67
+0.04%
Ishares Morningstar Value Etf
$23.67
+0.04%